Evaluating LED therapy for the Treatment of Mild Psoriasis
Research type
Research Study
Full title
Single Center, Randomized, Blinded, Controlled Trial Evaluating the Safety and Effectiveness of combined 453nm, 633nm and 830nm LED Light for the Treatment of Mild Plaque-Type Psoriasis Vulgaris
IRAS ID
245440
Contact name
Robin Stones
Contact email
Sponsor organisation
ISMART Marketing Svcs
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 12 months, 0 days
Research summary
The purpose of this study is to investigate whether light therapy can help improve plaque psoriasis. This is a study based on a new medical device. The device produces its light from light emitting diodes. This type of technology has been used for several years in the treatment of other skin conditions. However, we want to investigate the effect of a combination of very specific wavelengths of light on reducing the signs and symptoms of plaque psoriasis.
We are looking to recruit 25 people from the general population between the ages of 18 and 65 years old with mild to moderate plaque psoriasis and who are otherwise healthy. The light treatments are 5 times a week for 12 weeks and the treatment is self-administered at home. Each treatment is 15 minutes. The total duration of the study is 16 weeks.
This is a controlled trial. This means that we will treat one plaque with the light therapy device and the other plaque will remain untreated for the period of the study.REC name
North West - Greater Manchester West Research Ethics Committee
REC reference
18/NW/0554
Date of REC Opinion
26 Sep 2018
REC opinion
Further Information Favourable Opinion